NOTICE OF REFUND | Feb 5, 2015 | PAPER | BOARD |
Petitioner's Request for Refund | Jan 26, 2015 | PAPER | PETITIONER |
Decision - Denying Institution of Covered Business Method Patent Review | Jan 13, 2015 | PAPER | BOARD |
Finance Definition, Merriam-Webster.com | Jan 13, 2015 | EXHIBIT | BOARD |
Patent Owner Exhibit List | Oct 21, 2014 | PAPER | PATENT OWNER |
Patent Owner Preliminary Response | Oct 21, 2014 | PAPER | PATENT OWNER |
PR Newswire, FDA Issues GHB Warning (Nov. 8, 1990) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
FDA, Import Alert, Detention Without Physical Examination of Certain Steroid Alternatives (May 11, 1992) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Centers for Disease Control, Gamma Hydroxy Butyrate Use, New York and Texas, 1995-1996, MMWR 46(13) 281-83 (Apr. 4, 1997) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
NIDA, NIDA Community Drug Alert Bulletin, Club Drugs (Dec. 1999) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Office of National Drug Control Policy, Gamma Hydroxybutyrate (GHB) (Nov. 2002) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Date Rape Drugs, Hearing Before the Subcomm. on Oversight and Investigations of the H. Comm. on Commerce, 106th Cong., 58-66 (Mar. 11, 1999) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
SAMHSA, Advisory, GHB A Club Drug to Watch (Nov. 2002) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
NDIC, Information Bulletin GHB Analogs (Aug. 2002) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Controlled and Uncontrolled Substances Used to Commit Date Rape, Hearing Before the Subcomm. on Crime of the H. Comm. on the Judiciary, 105th Cong. (July 30, 1998) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Date Rape Drugs, Hearing Before the Subcomm. on Oversight Investigations of the H. Comm. on Commerce, 106th Cong. (Mar. 11, 1999) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000, Pub. L. No. 106-172, secs. 2(5)-(6), 114 Stat. 7, 7-8 (Feb. 18, 2000) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
146 Cong. Rec. H55-62 (daily ed. Jan. 31, 2000) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Letter from Dr. Robert Temple, Director, ODE I, to Dr. Dayton T. Reardan, Orphan Medical, Inc. (July 17, 2002) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Letter from Dr. Russell Katz, Director, Division of Neurology Products, ODE I, to Dr. Dayton T. Reardan, Orphan Medical, Inc. (Nov. 18, 2005) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Patent Quality Improvement Act of 2013, S. 866, 113th Cong. sec. 2(2) (2013) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Stopping the Offensive Use of Patents Act, H.R. 2766, 113th Cong. sec. 2(a)(2) (2013) | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Wayback Machine, Archive of the URL corresponding to PAR1004 | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Wayback Machine, Archive of the URL corresponding to PAR1005 | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Wayback Machine, Archive of the URL corresponding to PAR1006 | Oct 21, 2014 | EXHIBIT | PATENT OWNER |
Power of Attorney | Jul 30, 2014 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Jul 30, 2014 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Patent Owner Mandatory Notices | Jul 30, 2014 | PAPER | PATENT OWNER |
Notice of Filing Date Accorded to Petition | Jul 21, 2014 | PAPER | BOARD |
PETITION FOR COVERED BUSINESS METHOD PATENT REVIEW OF U.S. PATENT NO. 7,668,730 | Jul 9, 2014 | PAPER | PETITIONER |
Exhibit List | Jul 9, 2014 | PAPER | PETITIONER |
Power of Attorney | Jul 9, 2014 | PAPER | PETITIONER |
Power of Attorney | Jul 9, 2014 | PAPER | PETITIONER |
U.S. Patent No. 7,668,730 | Jul 9, 2014 | EXHIBIT | PETITIONER |
File History for Patent No. 7,668,730 | Jul 9, 2014 | EXHIBIT | PETITIONER |
Advisory Committee Meeting Transcript and Slides | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Preliminary Clinical Safety Review | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Briefing Booklet | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video Transcript | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 1 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 2 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 3 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 4 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 5 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 6 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 7 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 8 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 9 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 10 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 11 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 12 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 13 | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Xyrem Video - Part 14 | Jul 9, 2014 | EXHIBIT | PETITIONER |
Valuck Declaration | Jul 9, 2014 | EXHIBIT | PETITIONER |
CV of Robert Valuck | Jul 9, 2014 | EXHIBIT | PETITIONER |
Shulman, the Broader Message of Accutane | Jul 9, 2014 | EXHIBIT | PETITIONER |
Spurgeon, Advent of Mail-Order Pharmacy Causes Concern Among Some Pharmacists | Jul 9, 2014 | EXHIBIT | PETITIONER |
Honigfeld, Effects of the Clozapine National Registry System on Incidence of Deaths Relatd to Agranulocytosis | Jul 9, 2014 | EXHIBIT | PETITIONER |
Burleson, Review of Computer Applications in Institutional Pharmacy | Jul 9, 2014 | EXHIBIT | PETITIONER |
Zeldis, A Comprehensive Program for Controlling and Monitoring Access to Thalidomide | Jul 9, 2014 | EXHIBIT | PETITIONER |
Managing the Risks from Medical Product Use | Jul 9, 2014 | EXHIBIT | PETITIONER |
66 Fed. Reg. 24391 | Jul 9, 2014 | EXHIBIT | PETITIONER |
Intentionally Left Blank | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Meeting Documents by Center | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Internet Archive Wayback Machine | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Advisory Committee Briefing Information for Xyrem | Jul 9, 2014 | EXHIBIT | PETITIONER |
Advisory Committee Meeting 10.04.2001 | Jul 9, 2014 | EXHIBIT | PETITIONER |
Orange Book Entries for Xyrem | Jul 9, 2014 | EXHIBIT | PETITIONER |
Rome, Rave Culture and Illicit Drug Use in the Young | Jul 9, 2014 | EXHIBIT | PETITIONER |
FDA Approved Labeling | Jul 9, 2014 | EXHIBIT | PETITIONER |
Intentionally Left Blank | Jul 9, 2014 | EXHIBIT | PETITIONER |
Roxane Complaint | Jul 9, 2014 | EXHIBIT | PETITIONER |
Par Pharmaceutical Complaint | Jul 9, 2014 | EXHIBIT | PETITIONER |
Advisory Committees CDER 2001 Meeting Documents | Jul 9, 2014 | EXHIBIT | PETITIONER |
Wayback Machine Affidavit | Jul 9, 2014 | EXHIBIT | PETITIONER |
Mitchell, A Pregnancy-Prevention Program in Women of Childbearing Age | Jul 9, 2014 | EXHIBIT | PETITIONER |
U.S. Patent App. No. 20040019794 (Moradi) | Jul 9, 2014 | EXHIBIT | PETITIONER |
U.S. Patent App. No. 20030093295 (Lilly) | Jul 9, 2014 | EXHIBIT | PETITIONER |
Scrima 1989 | Jul 9, 2014 | EXHIBIT | PETITIONER |